Command Palette

Search for a command to run...

genomic-valley-biotech

31.8-0.09%
Market Cap
₹0.00 Cr
Stock P/E
0.00
ROCE
0.00%
ROE
0.00%
Book Value
₹0.00

You might have missed

No Recent News

No recent news available for this stock.

Shareholding

Holdings
Distribution
Promoter
Public
Others

From Last Concall

No Concall Summary

Conference call summary is not available for this stock.

Peers Summary

Sector Leader

In the Agriculture sector, Kaveri Seed Company Ltd. stands out as a strong performer due to its solid revenue growth and attractive valuation metrics. Genomic Valley Biotech Ltd., however, shows no growth or profitability metrics, making it an underperformer relative to its peers. Companies like Bombay Burmah Trading Corporation are identified as overvalued, while several peers exhibit signs of financial weakness.

Key Points
  • Kaveri Seed Company Ltd. leads in revenue growth and profitability metrics.
  • Genomic Valley Biotech Ltd. has no growth or profitability metrics, indicating underperformance.
  • Bombay Burmah Trading Corporation is identified as overvalued based on PE and PBV ratios.
Top Performers
Kaveri Seed Company Ltd.

Highest revenue growth (YoY and 3-Year) and strong ROE (20.67%) with attractive PEG ratio.

Bombay Burmah Trading Corporation Ltd.

Strong profitability with high ROE (42.87%) but high valuation metrics.

Leveling the playing field in markets.

© 2025 EQHQ Technologies Pvt Ltd

"Information provided is for educational purposes only and not financial advice.